CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Open-market sale Director sold 10,984 shares at an average $8.52 ($93,581)
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Medical Officer gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President gave up 4,953 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Neuroscience Product Dev. gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Neuroscience R&D gave up 2,476 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Liver Cirrhosis R&D gave up 2,476 shares (to pay taxes)
- 10-Q Report Quarterly Report
Page 10 of 26 · 511 filings